FDA Releases Updated Guidance on Public Availability of Advisory Committee Members' Financial Interest Information

Summary

The Food and Drug Administration (FDA) has published a new guidance document to inform the public, advisory committee members, and FDA staff about the procedures for disclosing and waiving financial interests related to advisory committee meetings, replacing a previous version from March 2012.